Scholars Central

Conference abstractPublished 2017

Novel compounds triggers HepG2 apoptotic cell

Authors: Suyun Jeong

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The study was performed to investigate the anti-cancer effect of novel compounds in the liver cancer. We performed with many synthetic compounds which are various forms of anti-cancers. We had screened test anti-cancer drugs and selected compatible two compounds. In the study, the anticancer effect and apoptotic molecular mechanism of two compounds were investigated on the human hepatocellular carcinoma cell, HepG2. The anti-proliferation effects of compounds on the HepG2 cell were analyzed using MTS. We showed the expression levels of anti-apoptotic (Bcl-2) proteins and apoptosisassociated proteins (Bax, caspase-3, PARP) using western blot. The results indicated that two compounds effectively inhibit cell proliferation and promote apoptosis and two compounds down-regulated the level of Bcl-2 protein and up-regulated the activity of Bax, cleaved-Parp, cleaved-Casepase-3 proteins. Therefore, two compounds induce apoptosis of hepG2 through the change of the apoptosis-associated proteins.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Archives in Cancer Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives in Cancer Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Suyun Jeong”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels